Zobrazeno 1 - 10
of 83
pro vyhledávání: '"L. A. Tashireva"'
Autor:
V. M. Perelmuter, E. S. Grigoryeva, O. E. Savelieva, V. V. Alifanov, E. S. Andruhova, M. V. Zavyalova, O. D. Bragina, E. Yu. Garbukov, M. E. Menyailo, A. A. Khozyainova, E. V. Denisov, N. V. Cherdyntseva, L. A. Tashireva
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Following the discovery of circulating tumor cells (CTCs) in the peripheral blood of cancer patients, CTCs were initially postulated to hold promise as a valuable prognostic tool through liquid biopsy. However, a decade and a half of accumul
Externí odkaz:
https://doaj.org/article/962192a563d74d2db34135b7524661bd
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 1, Pp 74-81 (2023)
Background. Lymph node metastasis in breast cancer is not only a variant of cancer progression, but is also associated with the development of hematogenous metastases. The LIMCH1 protein is involved in the mesenchymal type of migration due to the act
Externí odkaz:
https://doaj.org/article/fc2b09f74a93448eac5f13a04caafdb6
Autor:
O. V. Pankova, L. A. Tashireva, E. O. Rodionov, S. V. Мiller, T. S. Gerashchenko, D. S. Pismenny, M. E. Zavyalova, E. V. Denisov, V. M. Perelmuter
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 6, Pp 25-37 (2023)
Background. To select the optimal treatment for non-small cell lung cancer (NSCLC), it is important to predict the risk of distant metastasis and the effectiveness of therapy. The effect of neoadjuvant chemotherapy (NAC) on distant metastasis remains
Externí odkaz:
https://doaj.org/article/f06aab916cf44c66917dc40cc909644e
Autor:
L. A. Kolomiets, S. E. Krasil'nikov, N. E. Musaeva, D. Yu. Yukal'chuk, O. N. Churuksaeva, L. D. Zhuykova, N. M. Chernorubashkina, L. A. Tashireva, M. A.-K. Hodzhahova, O. V. Zharkova, E. N. Aleksandrova, V. N. Zhurman, A. A. Grechkina, V. G. Sisakyan, D. O. Pavlova, E. M. Pshevlocky, A. A. Gofman, A. V. Tarhov, A. V. Tereshchenko, N. A. Byuksel', A. A. Filippov, D. N. Kushlinsky
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 6, Pp 177-183 (2023)
Externí odkaz:
https://doaj.org/article/e02211346d0b418891d0662e6e99a4bb
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 4, Pp 6-12 (2023)
Aim. To determine informative prognostic criteria for assessing the HER2 / neu status in primary breast cancer using 99mTc-DARPinG3.Materials and methods. The study included 10 patients with breast cancer (T1-4N0-2M0) before systemic therapy, who und
Externí odkaz:
https://doaj.org/article/2dd19183a22944f5adfe4037be6d64d7
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 5, Pp 59-68 (2022)
Breast cancer is the most common cancer and the leading cause of cancer death in woman of childbearing age. Tumor progression depends on the character of stromal-parenchymal interactions. Tumor microenvironment exerts a key influence on tumor progres
Externí odkaz:
https://doaj.org/article/8338638d53744590af4f45165147fdc2
Autor:
M. V. Zavyalova, D. M. Loos, D. S. Pismenny, A. A. Durova, E. S. Andryukhova, E. O. Rodionov, S. V. Miller, S. A. Tuzikov, O. V. Pankova, L. A. Tashireva, S. V. Vtorushin, V. M. Perelmuter
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 5, Pp 69-81 (2022)
The aim of the study: to examine the relationship between the morphological diversity of non-small cell lung cancer and the frequency of lymph node metastasis in groups of patients with different epithelial conditions in the bronchi adjacent to the t
Externí odkaz:
https://doaj.org/article/ba516f1d1385401a8d8b0b48f2eec6a4
Autor:
L. A. Tashireva, N. O. Popova, V. V. Alifanov, V. E. Goldberg, E. I. Kovalenko, E. V. Artamonova, A. G. Manikhas, D. M. Ponomarenko, N. V. Levchenko, E. I. Rossokha, S. Yu. Krasilnikova, M. A. Zafirova, V. M. Perelmuter
Publikováno v:
Опухоли женской репродуктивной системы, Vol 17, Iss 4, Pp 48-55 (2022)
Background. Triple negative breast cancer has no specific treatment sites for chemotherapy and is unfavorable in terms of prognosis. One of the drugs widely used in this cohort of patients is eribulin, which in addition to its antimitotic effect has
Externí odkaz:
https://doaj.org/article/04fa079dcbd74e2faf1af1a6011b0a93
Autor:
V. M. Perelmuter, E. S. Grigorieva, M. V. Zavyalova, L. A. Tashireva, V. V. Alifanov, O. E. Saveleva, S. V. Vtorushin, E. L. Choynzonov, N. V. Cherdyntsevа
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 4 (2022)
Introduction. Ability of circulating tumor cells (CTC) initiate metastases in distant sites is associated primarily with their resistance to apoptosis which allows them to retain viability in the blood. Knowledge of phenotypical signs associated with
Externí odkaz:
https://doaj.org/article/e528649f1cf3493eb8d18b97772c0069
Autor:
D. S. Pismenny, O. E. Savelieva, M. V. Zavyalova, E. O. Rodionov, L. A. Tashireva, S. A. Tuzikov, O. V. Pankova, V. M. Perelmuter
Publikováno v:
Сибирский онкологический журнал, Vol 19, Iss 3, Pp 54-63 (2020)
Introduction. The development of inflammation is characterized by changes in blood hematology parameters and indices. Various inflammatory parameters are used to assess the inflammatory status (IS) during cancer treatment. Recent studies have reveale
Externí odkaz:
https://doaj.org/article/7268bbf69c584d3e8327b45dfb9bf9bc